Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune cells of the oral mucosa comprise an anatomically and functionally diverse group, including T lymphocytes, B lymphocytes, dendritic cells, macrophages, neutrophils, mast cells, and others. They function in pathogen defense, tolerance to commensal microbiota and food antigens, antigen presentation, cytokine secretion, and maintenance of tissue homeostasis. Specialized subpopulations inhabit distinct niches, such as the epithelial layers, lamina propria, mucosal lymphoid tissues, and salivary glands. Dysregulation of these cells underlies oral pathologies such as chronic inflammation, autoimmunity, and tumorigenesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune cell of oral mucosa.